As activation of the NF-κB pathway promotes the formation and development of colon cancer through inducing cell proliferation, angiogenesis, and cell metastasis and inhibiting cell apoptosis, NFKB1 is employed as a potential therapeutic target for colon cancer [92]. The gene discussed is NFKB1; the disease is colonic neoplasm.